KATHRYN LAPE: Open Payments
NPI 1396722377 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 53 payments from 21 companies in 2025. Trend: 2023 $1,114 · 2024 $997 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $243 |
| Novo Nordisk Inc | 6 | $120 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Amgen Inc. | 3 | $50 |
| Grifols USA, LLC | 3 | $50 |
| PFIZER INC. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| SHIELD THERAPEUTICS INC | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: QULIPTA, CAPLYTA, REXULTI, Prolastin-C Liquid, Ozempic, Wegovy, Auvelity, ACCRUFER.
Industry payments across PA — which companies pay providers there.
